Strides Pharma Science Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,323.47 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.78 per cent from ₹1,194.65 crore. This corresponds to a year-on-year *(YoY) growth of 11.18 per cent.
Operating Profit
Operating Profit stands at ₹233.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.29 per cent from ₹232.62 crore. This corresponds to a year-on-year *(YoY) growth of 22.50 per cent.
PBDT
PBDT stands at ₹201.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 32.02 per cent from ₹296.11 crore. This corresponds to a year-on-year *(YoY) growth of 29.68 per cent.
Profit Before Tax
Profit Before Tax stands at ₹148.05 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 39.69 per cent from ₹245.49 crore. This corresponds to a year-on-year *(YoY) growth of 39.18 per cent.
Net Profit
Net Profit stands at ₹129.28 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.88 per cent from ₹208.13 crore. This represents a 51.01 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Strides Pharma Science Ltd News
Strides Pharma Science Ltd Earnings
- YOY
- QOQ
Strides Pharma Science Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Strides Pharma Science Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Strides Pharma Science Ltd Financial Reports
Strides Pharma Science Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Strides Pharma | 2.67% | 0.79% | -3.43% | 8.04% | 30.60% | 21.16% |
| Blue Jet Health | -0.56% | -3.44% | 12.16% | 40.67% | 31.41% | -41.92% |
| Sanofi Consumer | -0.39% | 0.50% | -2.85% | -2.34% | 12.02% | -9.35% |
| Akums Drugs | -2.81% | -3.19% | 7.70% | 24.53% | 58.45% | 22.06% |
| Sanofi India | 0.16% | 1.56% | 1.86% | -4.90% | -15.58% | -42.30% |
| SPARC | -6.44% | -5.18% | -1.07% | 63.37% | 83.00% | 45.98% |
| Jeena Sikho | -2.37% | -0.38% | -6.77% | -16.32% | -19.14% | 5.40% |
Company Info
Company Information
Chairman & Non Executive Dir. : Arun Kumar
Executive Director / WTD / Managing Director / CEO : Badree Komandur
Independent Non Exe. Director : Kausalya Santhanam
Independent Non Exe. Director : Mukta Malik Arora
Independent Non Exe. Director : Homi R Khusrokhan
Independent Non Exe. Director : Ameet Hariani
Independent Non Exe. Director : Subir Chakraborty
Non Executive Director : Aditya Kumar
Company Sec. & Compli. Officer : Manjula Ramamurthy
Executive Director : VENKATA SEETHARAMA RAJU PAKALAPATI